The global in-vitro fertilization services market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. In-vitro fertilization is the process in which ovum (egg) is removed from a female’s ovaries, and sperm from a male is allowed to fertilize egg in a liquid in laboratory.
Market Trends, Drivers, Restraints, and Opportunities:
- Increasing disposable income and high success rates of in-vitro fertilization services is fueling the market.
- Rising infertility rate and delayed pregnancy is expected to drive the demand for in-vitro fertilization services in the coming years.
- Increasing costs and complications in IVF treatment is expected to hamper the market growth.
- Rising fertility tourism and fertility clinics is anticipated to provide lucrative opportunities for market players during the forecast period.
Scope of the report:
The report on in-vitro fertilization services market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
In-vitro fertilization services Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
By Product (In-vitro fertilization (IVF) and Intracytoplasmic sperm injection (ICSI)), Cycle Type (Donor Egg IVF, Thawed IVF Cycles (Non-donor), and Cycles Fresh IVF Cycles (Non-donor)), Age Group (Below 34, 35-39, 40-42, 43 and above), End-users (Hospitals, Fertility Clinics, Clinical Research Institutes, Surgical Centres, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Ambroise Paré Clinical Group, Bloom Fertility Centre, Bourn Hall, Chelsea and Westminster Hospital NHS Foundation Trust, Cyprus IVF Centre, Fertility Center Berlin, MANIPAL HEALTH ENTERPRISES PVT LTD, The Lister Hospital, Thomson Medical Pte Ltd, TRIO Fertility, Virtus Health, and Genea Perth Pty Ltd.
|
In-vitro fertilization services market Segment Insights:
The fresh IVF cycle segment is projected to hold significant market share
In terms of cycle types, the in-vitro fertilization services market can be segregated into donor egg IVF cycle, fresh IVF cycle, and thawed IVF cycle. The fresh IVF cycle segment held a considerable share of the market in 2020 owing to growing success rates of in-vitro fertilization. The thawed IVF cycle segment is estimated to expand at the significant CAGR during the forecast period owing to success rate in cases which are complicated such as in ovarian hyperstimulation syndrome.
The fertility clinics segment to grow during the forecast period
On the basis of end-users, the market can be segregated into fertility clinics, hospitals, surgical centers, clinical research institutes, and others. The fertility clinics segment is expected to hold a significant share of the market during the forecast period due to growing specialized healthcare professionals and rising number of fertility clinics.
The age group 35-39 segment to grow during the forecast period
Based on age groups, the market can be segregated into below 34, 35-39, 40-42, and 43 & above. The age group 35-39 segment is expected to hold a significant share of the market during the forecast period due to increasing pregnancy complexities.
The In-vitro fertilization (IVF) segment to grow during the forecast period
On the basis of products, the market can be bifurcated in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). The in-vitro fertilization (IVF) segment is anticipated to hold a significant share of the market during the forecast period due to increasing R&D and investment in this segment which ultimately propel the market.
Asia Pacific dominated the global market in 2020
In terms of regions, the global in-vitro fertilization services market can be split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific constituted a significant share of the market in 2020 due to mergers and acquisitions conducted by key market players. Moreover, countries like China and India, which has high population are driving the market in Asia Pacific. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period due to growing awareness in the IVF treatment and increasing disposable income.
Segments
Segments Covered in the Report
Product
- In-vitro Fertilization (IVF)
- Intracytoplasmic Sperm Injection (ICSI)
Cycle Type
- Donor Egg IVF Cycles
- Thawed IVF Cycles (Non-donor)
- Fresh IVF Cycles (Non-donor)
Age Group
- Below 34
- 35-39
- 40-42
- 43 and Above
End-users
- Hospitals
- Fertility Clinics
- Clinical Research Institutes
- Surgical Centers
- Others
Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players
- Ambroise Paré Clinical Group
- Bloom Fertility Centre
- Bourn Hall
- Chelsea and Westminster Hospital NHS Foundation Trust
- Cyprus IVF Centre
- Fertility Center Berlin
- MANIPAL HEALTH ENTERPRISES PVT LTD
- The Lister Hospital
- Thomson Medical Pte Ltd
- TRIO Fertility
- Virtus Health
- Genea Perth Pty Ltd.
Competitive Landscape
Key players in the in-vitro fertilization services market include Ambroise Paré Clinical Group, Bloom Fertility Centre, Bourn Hall, Chelsea and Westminster Hospital NHS Foundation Trust, Cyprus IVF Centre, Fertility Center Berlin, MANIPAL HEALTH ENTERPRISES PVT LTD, The Lister Hospital, Thomson Medical Pte Ltd, TRIO Fertility, Virtus Health, and Genea Perth Pty Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
Request For Customization
Enquiry Before Buying
Speak With Analyst
